Evaluation of insulin resistance in obese children and adolescents referred to a paediatric obesity outpatient clinic: a follow up study.

Evaluation of insulin resistance in obese children and adolescents referred to a paediatric obesity outpatient clinic: a follow up study. - CAIRO: Children and Adolescents with Insulin Resistance and Obesity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39352

Enrollment

Registered

2011-11-21

Start date

2011-12-06

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesitas insulin resistance

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Signed informed consent. The need for informed consent is waived in case parents/caregivers and subjects during the visit to the outpatient clinic did not make an objection orally against the use of their clinical data. In the latter case, routinely collected clinical and laboratory data will be used only.

Exclusion criteria

Exclusion criteria: Oral objection of subject and/or parents/caregivers for use of clinical data.

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: Primary endpoint is the HOMA-IR measured between 2-5 years after diagnosis of insulin resistance.	—

Secondary

Measure	Time frame
Secondary endpoints are BMI, FPG, T2DM and quality of life between 2-5 years after diagnosis of insulin resistance	—

Countries

Netherlands

Outcome results